Bisphosphonates and osteonecrosis: potential treatment or serious complication?
- PMID: 19358907
- DOI: 10.1016/j.ocl.2008.12.002
Bisphosphonates and osteonecrosis: potential treatment or serious complication?
Abstract
They are commonly used to treat osteoporosis and other diseases that involve osteoclast-mediated bone resorption, including Paget's disease and multiple myeloma. Their use in treating osteonecrosis of the femoral head has been studied and theoretically holds promise. There are complications associated with these medications, however, including the development of osteonecrosis in the jaw.
Similar articles
-
Complication related to bisphosphonate therapy: osteonecrosis of the jaw.J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373. J Infus Nurs. 2009. PMID: 19918142
-
Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.Oral Maxillofac Surg Clin North Am. 2007 May;19(2):199-206, vi. doi: 10.1016/j.coms.2007.01.005. Oral Maxillofac Surg Clin North Am. 2007. PMID: 18088878 Review.
-
Bisphosphonate-related osteonecrosis of the jaw: an overview.Ann N Y Acad Sci. 2011 Feb;1218:38-46. doi: 10.1111/j.1749-6632.2010.05768.x. Epub 2010 Sep 28. Ann N Y Acad Sci. 2011. PMID: 20946580 Review.
-
[Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].Therapie. 2007 Jan-Feb;62(1):49-54. doi: 10.2515/therapie:2007003. Epub 2007 Mar 21. Therapie. 2007. PMID: 17374348 French.
-
Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?Ir Med J. 2008 Jun;101(6):166-7. Ir Med J. 2008. PMID: 18700507 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical